New and emerging treatments for osteoporosis. [electronic resource]
Producer: 20070823Description: 364-9 p. digitalISSN:- 1040-8711
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Bone Density -- drug effects
- Bone Density Conservation Agents -- adverse effects
- Clinical Trials, Phase III as Topic
- Denosumab
- Diphosphonates -- adverse effects
- Drug Administration Routes
- Drug Administration Schedule
- Female
- Humans
- Ibandronic Acid
- Imidazoles -- adverse effects
- Osteoporosis, Postmenopausal -- drug therapy
- Patient Compliance
- RANK Ligand
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.